このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Intraoperative Neuromonitoring of Sacral Reflexes to Predict Post Operative Function in Patients Undergoing Sacrectomy for Pelvic Bone Malignancy or Patients Undergoing Spinal Procedures Without Sacral Root Involvement

2026年7月10日 更新者：City of Hope Medical Center

Phase 2a Prospective Study of Intraoperative Neuromonitoring of the Bulbocavernosus and External Urethral Sphincter Reflexes

This clinical trial tests how well monitoring the sacral reflexes during surgery (intraoperatively) works to predict the post operative function for patients undergoing removal of the lowest part of the spine (sacrectomy) for pelvic bone cancers or patients undergoing spinal procedures. These surgical procedures can lead to damage to sacral root nerves which can result in impairment to the lower extremities, bowel, bladder, and sexual function. Intraoperative monitoring of sacral reflexes can provide objective, real-time information about pelvic nerve function during surgery. This can aid surgical decision-making and help surgeons better prepare patients to understand the changes that may have occurred to their function as a result of surgery. Intraoperative neuromonitoring may work well to predict postoperative function in patients undergoing sacrectomy for pelvic bone malignancy or patients undergoing spinal procedures.

調査の概要

状態

まだ募集していません

条件

介入・治療

詳細な説明

PRIMARY OBJECTIVE:

I. To evaluate the feasibility of acquiring analyzable sacral reflex neuromonitoring data at baseline and case closure during surgery.

SECONDARY OBJECTIVES:

I. To characterize sacral reflex parameters amplitude, latency, waveform morphology, and Nerveana Power Index (NPI) at baseline under standardized intraoperative neuromonitoring conditions in patients undergoing spinal procedures without sacral nerve root involvement and patients undergoing sacrectomy.

II. To describe intraoperative changes in sacral reflex parameters from baseline to end-of-case during standardized intraoperative neuromonitoring in patients undergoing sacrectomy.

III. To characterize the relative contribution of individual sacral nerve roots to sacral reflex responses during intraoperative stimulation in patients undergoing sacrectomy.

IV. To characterize longitudinal changes in postoperative functional outcomes in patients undergoing sacrectomy.

EXPLORATORY OBJECTIVES:

I. To explore the association between intraoperative sacral reflex changes and postoperative functional outcomes in patients undergoing sacrectomy.

II. To explore the association between sacrifice of higher- versus lower-contributing sacral nerve roots and postoperative functional outcomes in patients undergoing sacrectomy.

OUTLINE:

Patients undergo neuromonitoring of the sacral reflexes at predefined time points during standard of care surgery.

After completion of study treatment, patients are followed up at 21 days, 6 weeks and 3, 6 and 12 months.

研究の種類

介入

入学 (推定)

50

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

  • アメリカ
    • California
      • Duarte、California、アメリカ、91010
        • City of Hope Medical Center
        • コンタクト：
        • 主任研究者：
          • Alana M. Munger

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Documented informed consent of the participant and/or legally authorized representative.

    • Assent, when appropriate, will be obtained per institutional guidelines
  • Age: ≥ 18 years
  • Ability to complete study questionnaires
  • Willingness to comply with all study procedures, including postoperative patient-reported outcome (PRO) assessments

  • Undergoing surgery at City of Hope involving either:

    • Complete or partial sacrectomy for primary or metastatic bone tumors, or
    • Thoracolumbar intervention in which the sacral roots are not exposed or manipulated (reference cohort)

Exclusion Criteria:

  • Prior sacrectomy or prior surgery resulting in complete sacral nerve transection
  • For thoracolumbar cohort patients, prior diagnosis or patient report of bowel or bladder dysfunction
  • Cognitive or psychiatric conditions preventing reliable completion of PRO instruments

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか？

デザインの詳細

  • 主な目的：診断
  • 割り当て：なし
  • 介入モデル：単一グループの割り当て
  • マスキング：なし（オープンラベル）

武器と介入

参加者グループ / アーム
介入・治療
実験的：Diagnostic (Intraoperative neuromonitoring)
Patients undergo neuromonitoring of the sacral reflexes at predefined time points during standard of care surgery.
他の：アンケート管理
補助研究
手順：外科的処置
標準治療の手術を受ける
他の名前：
  • 手術
  • 手術の種類
  • 外科的
  • 外科的介入
  • 外科処置
  • 手術、NOS
手順：Intraoperative Nerve Monitoring
Undergo intraoperative neuromonitoring
他の名前：
  • イオンム
  • Intraoperative Neuromonitoring
  • Intraoperative Neurophysiological Monitoring

この研究は何を測定していますか？

主要な結果の測定

結果測定
メジャーの説明
時間枠
Reproducible and interpretable bulbocavernosus reflex (BCR) and external urethral sphincter (EUS) reflex responses (feasibility)
時間枠：From baseline, Up to 1 year
Reproducible is defined as the ability to elicit a reflex response on repeated stimulation with consistent waveform presence and morphology at a given timepoint. Interpretable is defined as a recorded reflex response that is distinguishable from background noise and artifact and permits determination of response presence or absence and measurement of latency and amplitude. A two-sided 95% Clopper-Pearson confidence interval will be provided as a measure of precision.
From baseline, Up to 1 year

二次結果の測定

結果測定
メジャーの説明
時間枠
Distribution of BCR reflex parameters
時間枠：From baseline, Up to 1 year
Amplitude, latency, frequency distribution, etc, measured via intraoperative neuromonitoring (IONM). ), Analyses will first be conducted separately within thoracolumber and sacrectomy patient groups. Descriptive statistics will be reported for BCR for each group. Next, to compare the mean values between the two groups, t-test or Mann-Whitney U-test will be implemented depending on the distribution of these parameters. Additionally, within the sacrectomy group, the changes of these parameters from baseline to the end-of-case will be assessed either through paired t-test or Wilcoxon's signed rank test, depending on the distribution of each parameter.
From baseline, Up to 1 year
Distribution of EUS reflex parameters
時間枠：From baseline, Up to 1 year
Amplitude, latency, frequency distribution, etc, measured via IONM. Analyses will first be conducted separately within thoracolumber and sacrectomy patient groups. Descriptive statistics will be reported for EUS for each group. Next, to compare the mean values between the two groups, t-test or Mann-Whitney U-test will be implemented depending on the distribution of these parameters. Additionally, within the sacrectomy group, the changes of these parameters from baseline to the end-of-case will be assessed either through paired t-test or Wilcoxon's signed rank test, depending on the distribution of each parameter.
From baseline, Up to 1 year
Change in BCR reflex parameters
時間枠：From baseline, Up to 1 year
Analyses will first be conducted separately within thoracolumber and sacrectomy patient groups. Descriptive statistics will be reported for BCR for each group. Next, to compare the mean values between the two groups, t-test or Mann-Whitney U-test will be implemented depending on the distribution of these parameters. Additionally, within the sacrectomy group, the changes of these parameters from baseline to the end-of-case will be assessed either through paired t-test or Wilcoxon's signed rank test, depending on the distribution of each parameter.
From baseline, Up to 1 year
Change in EUS reflex parameters
時間枠：From baseline, Up to 1 year
Analyses will first be conducted separately within thoracolumber and sacrectomy patient groups. Descriptive statistics will be reported for EUS for each group. Next, to compare the mean values between the two groups, t-test or Mann-Whitney U-test will be implemented depending on the distribution of these parameters. Additionally, within the sacrectomy group, the changes of these parameters from baseline to the end-of-case will be assessed either through paired t-test or Wilcoxon's signed rank test, depending on the distribution of each parameter.
From baseline, Up to 1 year
Relative contribution of individual right sacral nerve roots to BCR amplitude
時間枠：During intraoperative stimulation, Up to Day 21
Amplitudes among sacrectomy patients will be descriptively reported.
During intraoperative stimulation, Up to Day 21
Relative contribution of individual left sacral nerve roots to BCR amplitude
時間枠：During intraoperative stimulation, Up to Day 21
Amplitudes among sacrectomy patients will be descriptively reported.
During intraoperative stimulation, Up to Day 21
Relative contribution of individual right sacral nerve roots to EUS amplitude
時間枠：During intraoperative stimulation, Up to Day 21
Amplitudes among sacrectomy patients will be descriptively reported.
During intraoperative stimulation, Up to Day 21
Relative contribution of individual left sacral nerve roots to EUS amplitude
時間枠：During intraoperative stimulation, Up to Day 21
Amplitudes among sacrectomy patients will be descriptively reported.
During intraoperative stimulation, Up to Day 21
Bowel function scores
時間枠：From baseline, Up to 1 year
Assessed by Memorial Sloan Kettering Bowel Function Instrument. Will be described by graphs and descriptive statistics at each time point.
From baseline, Up to 1 year
Bladder function scores
時間枠：From baseline, up to 1 year
Assessed by International Consultation on Incontinence Questionnaire. Will be described by graphs and descriptive statistics at each time point.
From baseline, up to 1 year
Sexual function scores
時間枠：From baseline, up to 1 year
Assessed by Female Sexual Function Index (female patients only) and International Index of Erectile Function (male patients only). Will be described by graphs and descriptive statistics at each time point.
From baseline, up to 1 year
Lower extremity function
時間枠：From baseline, up to 1 year
Assessed by Toronto Extremity Salvage Score for the Lower Extremity. Will be described by graphs and descriptive statistics at each time point.
From baseline, up to 1 year
Quality of life
時間枠：From baseline, up to 1 year
Assessed by Functional Assessment of Cancer Therapy-General. Will be described by graphs and descriptive statistics at each time point.
From baseline, up to 1 year
Postoperative urologic function
時間枠：From baseline, up to 1 year
Assessed by post-void residual (PVR) or cystometry. Will be described by graphs and descriptive statistics at each time point.
From baseline, up to 1 year

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

City of Hope Medical Center

協力者

National Cancer Institute (NCI)

捜査官

  • 主任研究者：Alana M Munger、City of Hope Medical Center

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2027年1月10日

一次修了 (推定)

2029年6月10日

研究の完了 (推定)

2029年6月10日

試験登録日

最初に提出

2026年7月10日

QC基準を満たした最初の提出物

2026年7月10日

最初の投稿 (実際)

2026年7月16日

学習記録の更新

投稿された最後の更新 (実際)

2026年7月16日

QC基準を満たした最後の更新が送信されました

2026年7月10日

最終確認日

2026年7月1日

詳しくは

本研究に関する用語

追加の関連 MeSH 用語

その他の研究ID番号

  • 25826 (その他の識別子：City of Hope Medical Center)
  • P30CA033572 (米国 NIH グラント/契約)
  • NCI-2026-04599 (レジストリ識別子：CTRP (Clinical Trial Reporting Program))

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する